Integris Medtech files DRHP with SEBI for ₹3,500–4,000 crore IPO
Integris Medtech filed for a ₹3,500–4,000 crore IPO, combining fresh issue and OFS to fund expansion and strengthen balance sheet.
Live Market Updates
Latest Financial News
Stay ahead with real-time financial news, market insights, and expert analysis from trusted sources worldwide
News Feed
1 articles
Live Market Updates
Latest Financial News
Stay ahead with real-time financial news, market insights, and expert analysis from trusted sources worldwide
positive
5h agoIntegris Medtech files DRHP with SEBI for ₹3,500–4,000 crore IPO
Everstone-backed Integris Medtech has filed its Draft Red Herring Prospectus (DRHP) with SEBI to raise between ₹3,500 crore and ₹4,000 crore. The issue includes a fresh equity component of ₹925 crore and an offer-for-sale (OFS) of 2.16 crore shares by promoters and existing investors. The firm operates in medical devices, diagnostics, and lab automation, with FY25 revenue at ₹1,959.58 crore. Proceeds will fund expansion, debt reduction, and R&D capacity building across India and global subsidiaries.
positive
5h agoIntegris Medtech files DRHP with SEBI for ₹3,500–4,000 crore IPO
Everstone-backed Integris Medtech has filed its Draft Red Herring Prospectus (DRHP) with SEBI to raise between ₹3,500 crore and ₹4,000 crore. The issue includes a fresh equity component of ₹925 crore and an offer-for-sale (OFS) of 2.16 crore shares by promoters and existing investors. The firm operates in medical devices, diagnostics, and lab automation, with FY25 revenue at ₹1,959.58 crore. Proceeds will fund expansion, debt reduction, and R&D capacity building across India and global subsidiaries.
Breaking
positive
Integris Medtech files DRHP with SEBI for ₹3,500–4,000 crore IPO
about 6 hours ago
1 min read
75 words
Integris Medtech filed for a ₹3,500–4,000 crore IPO, combining fresh issue and OFS to fund expansion and strengthen balance sheet.
Everstone-backed Integris Medtech has filed its Draft Red Herring Prospectus (DRHP) with SEBI to raise between ₹3,500 crore and ₹4,000 crore. The issue includes a fresh equity component of ₹925 crore and an offer-for-sale (OFS) of 2.16 crore shares by promoters and existing investors. The firm operates in medical devices, diagnostics, and lab automation, with FY25 revenue at ₹1,959.58 crore. Proceeds will fund expansion, debt reduction, and R&D capacity building across India and global subsidiaries.
Everstone-backed Integris Medtech has filed its Draft Red Herring Prospectus (DRHP) with SEBI to raise between ₹3,500 crore and ₹4,000 crore. The issue includes a fresh equity component of ₹925 crore and an offer-for-sale (OFS) of 2.16 crore shares by promoters and existing investors. The firm operates in medical devices, diagnostics, and lab automation, with FY25 revenue at ₹1,959.58 crore. Proceeds will fund expansion, debt reduction, and R&D capacity building across India and global subsidiaries.
Companies:
Integris Medtech
Tags:
Integris Medtech
IPO India
Integris Medtech
IPO India
DRHP
medical devices
Everstone
Source: